| [1]ABDALLAH R,ATAR S.Etiology and characteristics of large symptomatic pericardial effusion in a community hospital in the contemporary era[J].QJM,2014,107(5):363-368.
[2]HOIT B D.Management of effusive and constrictive pericardial heart disease[J].Circulation,2002,105(25):2939-2942.
[3]PERMANYER-MIRALDA G,SAGRIST-SAULEDA J,SOLER-SOLER J.Primary acute pericardial disease:a prospective series of 231 consecutive patients[J].Am J Cardiol,1985,56(10):623-630.
[4]CHEN Y,BRENNESSEL D,WALTERS J,et al.Human immunodeficiency virus-associated pericardial effusion:report of 40 cases and review of the literature[J].Am Heart J,1999,137(3):516-521.
[5]KABANGILA R,MAHALU W,MASALU N,et al.Recurrent,massive Kaposi’s sarcoma pericardial effusion presenting without cutaneous lesions in an HIV infected adult:a case report[J].Tanzan J Health Res,2011,13(1):103-105.
[6]MA W,LIU J,ZENG Y,et al.Causes of moderate to large pericardial effusion requiring pericardiocentesis in 140 Han Chinese patients[J].Herz,2012,37(2):183-187.
[7]LEVY P Y,COREY R,BERGER P,et al.Etiologic diagnosis of 204 pericardial effusions[J].Medicine(Baltimore),2003,82(6):385-391.
[8]ILINGIROGLU M,AKKUS N,SETHI S,et al.Large pericardial effusion induced by minoxidil[J].Turk Kardiyol Dern Ars,2012,40(3):255-258.
[9]MAISCH B,SEFEROVIC P M,RISTIC A D,et al.Guidelines on the diagnosis and management of pericardial diseases.Executive summary[J].Rev Esp Cardiol,2004,57(11):1090-1114.
[10]SONG J M,SHIM T S,CHOI S W,et al.Diagnosis of tuberculous pericardial effusion by T cell-based assays on peripheral blood and pericardial fluid mononuclear cells[J].JACC,2012,59(13):E1589.
[11]NANJO S,YAMAZAKI J,TSUBUKU M,et al.Primary idiopathic chylopericardium:report of two cases[J].Ann Nucl Med,2004,18(6):537-539.
[12]ZZOTTA G,MORAIS J A,OTO A,et al.Guidelines on the diagnosis and management of pericardial diseases[J].Eur Heart J,2004,25(7):587-610.
[13]ADLER Y,CHARRON P,IMAZIO M,et al.2015 ESC Guidelines for the diagnosis and management of pericardial diseases[J].Kardiol Pol,2015,73(11):1028-1091.
[14]IMAZIO M,BOBBIO M,CECCHI E,et al.Colchicine in addition to conventional therapy for acute pericarditis:results of the COlchicine for acute PEricarditis(COPE) trial[J].Circulation,2005,112(13):2012-2016.
[15]IMAZIO M,DEMICHELIS B,PARRINI I,et al.Day-hospital treatment of acute pericarditis:a management program for outpatient therapy[J].J Am Coll Cardiol,2004,43(6):1042-1046.
[16]IMAZIO M,BELLI R,BRUCATO A,et al.Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis(CORP-2):a multicentre,double-blind,placebo-controlled,randomized trial[J].Lancet,2014,383(9936):2232-2237.
[17]IMAZIO M,TRINCHERO R,BRUCATO A,et al.COlchicine for the Prevention of the Post-pericardiotomy Syndrome(COPPS):a multicentre,randomized,double-blind,placebo-controlled trial[J].Eur Heart J,2010,31(22):2749-2754.
[18]IMAZIO M,BRUCATO A,FERRAZZI P,et al.Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation:the COPPS-2 randomized clinical trial[J].JAMA,2014,312(10):1016-1023.
[19]MAYOSI B M,NTSEKHE M,BOSCH J,et al.Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis[J].N Eng J Med,2014,371(12):1121-1130.
[20]IMAZIO M,BRUCATO A,CUMETTI D,et al.Corticosteroids for recurrent pericarditis high versus low doses:a nonrandomized observation[J].Circulation,2008,118(6):667-671.
[21]RISTIC A D,IMAZIO M,ADLER Y,et al.Triage strategy for urgent management of cardiac tamponade:a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases[J].Eur Heart J,2014,35(34):2279-2284.
[22]HEMNES A R,GAINE S P,WIENER C M.Poor outcomes associated with drainage of pericardial effusions in patients with pulmonary arterial hypertension[J].South Med J,2008,101(5):490-494.
[23]FENSTAD E R,LE R J,SINAK L J,et al.Pericardial effusions in pulmonary arterial hypertension:characteristics,prognosis,and role of drainage[J].Chest,2013,144(5):1530-1538.
[24]TOH U,FUJII T,SEKI N,et al.Characterization of IL-2-activated TILs and their use in intrapericardial immunotherapy in malignant pericardial effusion[J] Cancer Immunol Immunother,2006,55(10):1219-1227.
[25]崔翰斌,陈新义,崔长琮,等.经导管心包内尿激酶灌洗预防心包缩窄的临床研究[J].中华心血管病杂志,2004,32(12):1118-1122.
CUI H B,CHEN X Y,CUI C Z,et al.Transcatheter intrapericardial fibrinolysis can prevent the development of pericardial constriction[J].Chinese Journal of Cardiology,2004,32(12):1118-1122.
[26]REUTER H,BURGESS L J,LOUW V J,et al.The management of tuberculous pericardial effusion:experience in 233 consecutive patients[J].Cardiovasc J S Afr,2007,18(1):20-25.
[27]MAYOSI B M,NTSEKHE M,VOLMINK J A,et al.Interventions for treating tuberculous pericarditis[J].Cochrane Database Syst Rev,2002(4):CD00526.
[28]AKAMATSU H,AMANO J,SAKAMOTO T,et al.Primary chylopericardium[J].Ann Thorac Surg,1994,58(1):262-266.
[29]MELDUNI R M,OH J K,BUNCH T J,et al.Reconstruction of occluded thoracic duct for treatment of chylopericardium:a novel surgical therapy[J].J Vasc Surg,2008,48(6):1600-1602.
[30]HEIDENREICH P A,EISENBERG M J,KEE L L,et al.Pericardial effusion in AIDS incidence and survival [J].Circulation,1995,92(11):3229-3234.
[31]KIL U H,JUNG H O,KOH Y S,et al.Prognosis of large,symptomatic pericardial effusion treated by echo-guided percutaneous pericardiocentesis[J].Clin Cardiol,2008,31(11):531-537.
[32]MAYOSI B M,WIYSONGE C S,NTSEKHE M,et al.Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa[J].S Afr Med J,2008,98(1):36-40.
[33]MAYOSI B M,BURGESS L J,DOUBELL A F.Tuberculous pericarditis[J].Circulation,2005,112(23):3608-3616.
[34]SAGRIST-SAULEDA J,MERC J,PERMANYER-MIRALDA G,et al.Clinical clues to the causes of large pericardial effusions[J].Am J Med,2000,109(2):95-101.
[35]SAGRIST-SAULEDA J,ANGEL J,PERMANYER-MIRALDA G,et al.Long-term follow-up of idiopathic chronic pericardial effusion[J].N Engl J Med,2012,341:2054-2059. |